Page 10 - Immune Sciences News Today

HC Wainwright reiterated their buy rating on shares of Alpine Immune Sciences (NASDAQ:ALPN – Free Report) in a research note released on Thursday, Benzinga reports. They currently have a $17.00 price target on the biotechnology company’s stock. Separately, Wedbush boosted their target price on Alpine Immune Sciences from $17.00 to $19.00 and gave the stock […]

Alpine Immune Sciences (NASDAQ: ALPN) has recently received a number of price target changes and ratings updates: 9/1/2023 – Alpine Immune Sciences had its “outperform” rating reaffirmed by analysts at Wedbush. They now have a $19.00 price target on the stock. 8/31/2023 – Alpine Immune Sciences had its “buy” rating reaffirmed by analysts at HC […]

Alpine Immune Sciences (NASDAQ:ALPN – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at Wedbush in a research note issued to investors on Friday, Benzinga reports. They presently have a $19.00 target price on the biotechnology company’s stock. Wedbush’s price objective would suggest a potential upside of 47.29% from the stock’s […]

Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced the appointment of...

Investment Analysts’ price target changes for Tuesday, August 15th: Arcellx (NASDAQ:ACLX) had its price target increased by HC Wainwright from $49.00 to $50.00. The firm currently has a buy rating on the stock. Arcellx (NASDAQ:ACLX) had its target price increased by Robert W. Baird from $40.00 to $52.00. They currently have an outperform rating on […]

Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s share price hit a new 52-week high during trading on Tuesday after Wedbush raised their price target on the stock from $17.00 to $19.00. Wedbush currently has an outperform rating on the stock. Alpine Immune Sciences traded as high as $14.92 and last traded at $13.99, […]

Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) saw an uptick in trading volume on Monday . 51,423 shares traded hands during trading, a decline of 64% from the previous session’s volume of 141,744 shares.The stock last traded at $13.52 and had previously closed at $13.58. Alpine Immune Sciences Trading Down 2.0 % The […]

Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) saw unusually-strong trading volume on Monday . Approximately 477,690 shares traded hands during trading, an increase of 256% from the previous session’s volume of 134,176 shares.The stock last traded at $12.60 and had previously closed at $12.20. Alpine Immune Sciences Stock Performance The firm […]

Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 477,690 shares changed hands during trading, an increase of 256% from the previous session’s volume of 134,176 shares.The stock last traded at $12.60 and had previously closed at $12.20. Alpine Immune Sciences Price Performance The company has […]

Key Insights The considerable ownership by private equity firms in Alpine Immune Sciences indicates that they...